Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeTax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Exozymes (EXOZ) Research & Development (2023 - 2024)

Exozymes (EXOZ) has disclosed Research & Development for 2 consecutive years, with $1.8 million as the latest value for Q4 2024.

  • Quarterly Research & Development rose 299.56% to $1.8 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Dec 2024, changed N/A year-over-year, with the annual reading at $95989.0 for FY2025, 94.86% down from the prior year.
  • Research & Development for Q4 2024 was $1.8 million at Exozymes, up from $15661.0 in the prior quarter.
  • The five-year high for Research & Development was $1.8 million in Q4 2024, with the low at $15661.0 in Q3 2024.